Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1

Conditions

Multiple Pulmonary Nodules 1Lung Neoplasms 1Liver Neoplasms 1Hemorrhage 1Blood Loss, Surgical 1

Interventions

pembrolizumab 589Cyclophosphamide 539Magnetic Resonance Spectroscopy 523Radiotherapy 506Specimen Handling 503Nivolumab 407Cisplatin 370Carboplatin 358Biopsy 304Blood Specimen Collection 295Radiosurgery 283Paclitaxel 274Surveys and Questionnaires 268Standard of Care 266Gemcitabine 265fludarabine 261Dexamethasone 258Drug Therapy 256venetoclax 246Bevacizumab 246Oxaliplatin 206Rituximab 195Capecitabine 194Radiation 189Fluorouracil 186Ipilimumab 184durvalumab 180Doxorubicin 175atezolizumab 172Etoposide 171

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Neuromuscular Blockade × 1 year × Clear all
NCT07395375 2026-02-09

NIVA-TSLR

The First Affiliated Hospital of Guangzhou Medical University

Phase NA Not yet recruiting
1,600 enrolled
Thoracic

Lung Neoplasms, Multiple Pulmonary Nodules

NCT04609410 2025-08-07

MODELS

Università Vita-Salute San Raffaele

Phase NA Terminated
48 enrolled
Gastrointestinal

Hemorrhage, Liver Neoplasms, Blood Loss, Surgical

Data powered by HemOnc (CC BY 4.0) Colophon âš¡